- Home
- STOK vs LYTS Comparison
STOK vs LYTS Comparison
Compare STOK & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- LYTS
- Stock Information
- Founded
- STOK 2014
- LYTS 1976
- Country
- STOK United States
- LYTS United States
- Employees
- STOK N/A
- LYTS N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- LYTS Building Products
- Sector
- STOK Health Care
- LYTS Consumer Discretionary
- Exchange
- STOK Nasdaq
- LYTS Nasdaq
- Market Cap
- STOK 721.4M
- LYTS 595.4M
- IPO Year
- STOK 2019
- LYTS N/A
- Fundamental
- Price
- STOK $11.45
- LYTS $20.10
- Analyst Decision
- STOK Strong Buy
- LYTS Strong Buy
- Analyst Count
- STOK 7
- LYTS 2
- Target Price
- STOK $21.40
- LYTS $19.00
- AVG Volume (30 Days)
- STOK 562.4K
- LYTS 94.8K
- Earning Date
- STOK 11-05-2024
- LYTS 01-23-2025
- Dividend Yield
- STOK N/A
- LYTS 1.00%
- EPS Growth
- STOK N/A
- LYTS N/A
- EPS
- STOK N/A
- LYTS 0.78
- Revenue
- STOK $16,742,999.00
- LYTS $484,292,000.00
- Revenue This Year
- STOK $103.04
- LYTS $17.21
- Revenue Next Year
- STOK N/A
- LYTS $9.55
- P/E Ratio
- STOK N/A
- LYTS $25.36
- Revenue Growth
- STOK 81.08
- LYTS N/A
- 52 Week Low
- STOK $4.09
- LYTS $13.32
- 52 Week High
- STOK $17.58
- LYTS $21.19
- Technical
- Relative Strength Index (RSI)
- STOK 41.75
- LYTS 54.07
- Support Level
- STOK $11.80
- LYTS $19.73
- Resistance Level
- STOK $12.58
- LYTS $21.19
- Average True Range (ATR)
- STOK 0.83
- LYTS 0.49
- MACD
- STOK -0.06
- LYTS -0.14
- Stochastic Oscillator
- STOK 8.32
- LYTS 28.42
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About LYTS LSI Industries Inc.
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.